Content
09/03/2024
Minneapolis, MN USA
Melodi Health
completed $10.75 million Series A Round funding. Investors include
Engage, HM Venture Partners, Southeast Minnesota Capital Fund, Three Bridges Private Capital.
About
Melodi Health offers novel technologies that improve patient outcomes for women undergoing breast surgery.
Melodi Health manufactures the Melodi Matrix, designed to support the soft tissue space around a prosthetic device while delivering antibiotics to the surrounding tissue. The Melodi Matrix is currently an investigational device being studied in a prospective, multi-center, randomized, controlled clinical trial in breast reconstruction.
Startup
Sector:
MedTech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
